The effects of 8-arm-PEG-catechol/heparin shielding system and immunosuppressive drug, FK506 on the survival of intraportally allotransplanted islets

Bok Hyeon Im, Jee Heon Jeong, Muhammad R. Haque, Dong Yun Lee, Cheol Hee Ahn, Ju Eun Kim, Youngro Byun

Research output: Contribution to journalArticle

25 Scopus citations

Abstract

This study proposed a double-layer shielding method of using 8-arm-PEG-catechol (PEG8) and N-hydroxysuccinimidyl-linked unfractionated heparin (UFH-NHS) for the prevention of instant blood-mediated inflammatory reaction (IBMIR) and immune reactions against transplanted pancreatic islets. The surface of islet was evenly covered by PEG8 and UFH-NHS. Both viability and functionality of islets were evaluated in vitro, and the anti-coagulation effect of conjugated heparin on the islet surface was also evaluated. The inhibition effects of PEG8/UFH double-layer shielding system on immune reactions and IBMIR induced by transplanted islets were evaluated in an allograft model. When pancreatic islets of Sprague-Dawley (SD) rats were transplanted in the liver of F344 rats, the mean survival time (MST) of PEG8/UFH double-layer shielded islets (6.8 ± 1.6 days) was statistically increased, compared to that of unmodified islets (3.6 ± 1.1 days). Furthermore, when 0.5 mg/kg of FK506 was daily administered, the MST of double-layer shielded islet (15.0 ± 2.1 days) was increased by two-fold, compared to that of unmodified islets treated with the same dose of FK506 (8.0 ± 2.4 days). Therefore, a newly developed strategy of combining the PEG8/UFH double-layer shielding system with FK506 would certainly be effective for preventing immune activation and IBMIR against allotransplanted islets.

Original languageEnglish
Pages (from-to)2098-2106
Number of pages9
JournalBiomaterials
Volume34
Issue number8
DOIs
StatePublished - 2013 Mar 1

Keywords

  • 8-arm-PEG
  • Double-layer shielding
  • FK506
  • Heparin
  • Islet transplantation
  • Pancreatic islets

Fingerprint Dive into the research topics of 'The effects of 8-arm-PEG-catechol/heparin shielding system and immunosuppressive drug, FK506 on the survival of intraportally allotransplanted islets'. Together they form a unique fingerprint.

  • Cite this